Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00483249 · ClinicalTrials.gov registry record · NA

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

A NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm, sponsored by Warren J. Gasper, MD.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT00483249 is a NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm that is actively recruiting participants, run by Warren J. Gasper, MD. The registered enrollment target is 250 participants, above the 177-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (41% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00483249, a NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by Warren J. Gasper, MD.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Interventions

  • DEVICE Endovascular Branched Stent-Graft

Study Locations (2)

California

  • Division of Vascular Surgery, SFVAMC - San Francisco
  • Division of Vascular Surgery, UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2005-05
Est. Completion 2027-12
Phase NA

Sponsor

Warren J. Gasper, MD

1 total trials

What the Registry Record Tells You About NCT00483249

The ClinicalTrials.gov registry entry for NCT00483249 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 177-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (41% higher). The listed sponsor is Warren J. Gasper, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Thoracoabdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Endovascular Branched Stent-Graft is the first listed.

NCT00483249 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00483249 about?

NCT00483249 is a clinical study titled "Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm". This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

What is the current status of trial NCT00483249?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2005-05. Estimated completion is 2027-12.

What conditions does trial NCT00483249 study?

This clinical trial studies the following conditions: Thoracoabdominal Aortic Aneurysm, Paravisceral Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT00483249?

The interventions under investigation include: Endovascular Branched Stent-Graft (DEVICE).

Who is sponsoring clinical trial NCT00483249?

This trial is sponsored by Warren J. Gasper, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00483249 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracoabdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.